Two former Geron CEOs make a bid for the company’s defunct human embryonic stem cell business.
Two former Geron CEOs make a bid for the company’s defunct human embryonic stem cell business.
In a Phase I trial, researchers show that neural stem cells transplanted into humans can differentiate and begin producing myelin.
Page 1 of 1